Strong travel demand and the company's record-setting results could set ISPO stock up for a powerful rebound this year. More
Articles
Clover Health’s Technology Is Great But With Dead Money
Clover Health has interesting technology, but unless it can end losses this year it may not have a 2023. It has great technology but may lack the financial strength to make it in the Medicare Advantage arena. More
Lucid Group May Have All the Time in the World
Although LCID stock is experiencing near-term pricing woes, it may be a discounted opportunity since EV integration will take time. More
Raytheon Technologies Stock Is Your Best Defense in Turbulent Times
RTX stock offers not only strong value and a solid dividend yield, but also assurance for investors concerned about market volatility. More
